Literature DB >> 16438503

Synthesis of the enediol isofurans, endogenous oxidation products of arachidonic acid.

Douglass F Taber1, Zhe Zhang.   

Abstract

Isofurans (IsoF's) are a new class of human arachidonic acid oxidation products. They are produced in vivo by a free radical mechanism, independent of the cyclooxygenase enzymes. These new compounds are available from natural sources only in microgram quantities as mixtures. The enantioselective preparation of two enediol isofurans, 15-epi-ent-SC-Delta13-8-IsoF and ent-SC-Delta13-8-IsoF, is described. A key transformation in the synthesis is the selective cascade cyclization of a diol epoxide benzenesulfonate to give the substituted tetrahydrofuran skeleton of the isofurans. This synthesis will make these metabolites available for physiological evaluation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438503     DOI: 10.1021/jo051889a

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Quasi-Biomimetic Ring Contraction Catalyzed by a Cysteine-Based Nucleophile: Total Synthesis of Sch-642305, Some Analogs and their Putative anti-HIV Activities.

Authors:  Alpay Dermenci; Philipp S Selig; Robert A Domaoal; Krasimir A Spasov; Karen S Anderson; Scott J Miller
Journal:  Chem Sci       Date:  2011-08-01       Impact factor: 9.825

2.  Epoxygenase eicosanoids: synthesis of tetrahydrofuran-diol metabolites and their vasoactivity.

Authors:  J R Falck; L Manmohan Reddy; Kihwan Byun; William B Campbell; Xiu-Yu Yi
Journal:  Bioorg Med Chem Lett       Date:  2007-02-02       Impact factor: 2.823

3.  A divergent synthesis of the delta(13)-9-isofurans.

Authors:  Douglass F Taber; Peiming Gu; Rui Li
Journal:  J Org Chem       Date:  2009-08-07       Impact factor: 4.354

Review 4.  Synthetic applications of chiral unsaturated epoxy alcohols prepared by sharpless asymmetric epoxidation.

Authors:  Antoni Riera; María Moreno
Journal:  Molecules       Date:  2010-02-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.